Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial

Circulation - United States
doi 10.1161/circulationaha.110.937409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Follow-Up of Implantable Cardioverter-Defibrillator Therapy: Comparison of Coronary Artery Disease and Dilated Cardiomyopathy

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2014English

Remote Monitoring and Follow-Up of Cardiovascular Implantable Electronic Devices in the Netherlands

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2012English

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator

Journal of Clinical Medicine
2018English

Should Physicians Instead of Industry Representatives Be the Main Actor of Cardiac Implantable Electronic Device Follow-Up? (Super Follow-Up)

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2017English

Data, Monitoring and Follow-Up

Report of the Inter-Agency Task Force on Financing for Development
2018English

Data, Monitoring and Follow-Up

2020English

Data, Monitoring and Follow-Up

2019English

Validation of an Organizational Management Model of Remote Implantable Cardioverter-Defibrillator Monitoring Alerts

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2015English

Evolution, Evaluation, and Efficacy of Implantable Cardioverter- Defibrillator Technology

Circulation
Cardiovascular MedicinePhysiologyCardiology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy